Company news

Share this article:
Revolution Health and EmergingMed announced a partnership to offer a new cancer clinical trial matching service for patients and physicians. “EmergingMed is committed to providing personalized services to patients who are exploring treatment options,” said Courtney Hudson, EmergingMed founder and CEO in a statement. “We believe patients should have access to the latest research options targeting their specific diagnoses.” The service is available for online searching, as well as by telephone.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.